Top Experiences of the Day (ABT, DOLE, SKUL, CBPO)

New York, NY -- (SBWIRE) -- 01/02/2013 -- Abbott Laboratories (NYSE:ABT) announced it has completed the separation of its research-based pharmaceuticals business, which became AbbVie, a new independent biopharmaceutical company. AbbVie will begin trading independently on the New York Stock Exchange January 02, 2013 under the symbol ABBV.ABT reported EPS in 4.088. For the Current Fiscal year, the company is expected to report EPS of 5.06. For the Next Quarter and Next Year, the company is expected to report EPS of 1.12 and 5.23 respectively. At Current Market Price, ABT is in distance of -50.41% from its 50-day Moving Average price of $64.7447 and -51.32% from its 200-day Moving Average price of $65.9578.

Will ABT Rebound After Today’s Slump? Find Out Here

Dole Food Company, Inc. (NYSE:DOLE) is a producer, marketer and distributor of fresh fruit and fresh vegetables. The Company is a producer of bananas and pineapples, and packaged fruit products, packaged salads and fresh-packed vegetables. The Company has three business segments: fresh fruit, fresh vegetables and packaged foods. Shares of Dole Food Company (NYSE: DOLE) were also down, giving up 14.21 percent to $9.84 after the company announced that it expects to close its sale of Worldwide Packed foods.

How Should Investors Trade DOLE Now? Free Sign Up Here

Skullcandy, Inc. (NASDAQ:SKUL) is -0.98 - -12.58% from the previous close of $7.79. It traded between $6.55 - 7.79 with total traded volume of 1826702 shares. Keep a close eye on SKUL, as the stock has been showing unusual moves over the past weeks. At Current market price, SKUL has recovered -11.56% from its 52-week Low of 7.70 and has Pulled back -61.66% from its 52-week high of 17.76.

How Should Investors React To SKUL Now? Find Out Here

China Biologic Products, Inc. (NASDAQ:CBPO) are a biopharmaceutical company. The Company through our indirect majority-owned People’s Republic of China subsidiaries, Shandong Taibang Biological Products Co. Ltd. (Shandong Taibang) and Guizhou Taibang Biological Products Co., Ltd. (Guizhou Taibang), and its minority-owned People’s Republic of China invested, Xi’an Huitian Blood Products Co., Ltd (Huitian), principally engaged in the research, development, manufacturing and sales of human plasma-based pharmaceutical products in China. CBPO is -1.541 - -9.45% from the previous close of $16.31. It traded between $13.07 - 15.69 with total traded volume of 112083 shares. Keep a close eye on CBPO, as the stock has been showing unusual moves over the past weeks. At Current market price, CBPO has recovered +108.90% from its 52-week Low of 7.07 and has Pulled back -14.03% from its 52-week high of 17.18.

Should Invest Buy OR Sell This Stock: CLICK HERE

DISCLAIMER
Neither PennyStocksUpdate.biz nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by PennyStocksUpdate.biz, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation.PennyStocksUpdate.biz makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through PennyStocksUpdate.biz. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned here in..

Contact:
PennyStocksUpdate.biz
info@pennystocksupdate.biz